These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19465161)

  • 1. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3B polymorphisms and risk of primary lung cancer.
    Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
    Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
    Shen H; Wang L; Spitz MR; Hong WK; Mao L; Wei Q
    Cancer Res; 2002 Sep; 62(17):4992-5. PubMed ID: 12208751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population.
    Aung PP; Matsumura S; Kuraoka K; Kunimitsu K; Yoshida K; Matsusaki K; Nakayama H; Yasui W
    Oncol Rep; 2005 Nov; 14(5):1151-4. PubMed ID: 16211278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
    Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.
    Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN
    Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study.
    Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN
    Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
    Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
    Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
    Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
    Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
    Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.
    Jones JS; Amos CI; Pande M; Gu X; Chen J; Campos IM; Wei Q; Rodriguez-Bigas M; Lynch PM; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):886-91. PubMed ID: 16702365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma.
    Akil A; Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; Diagne AG; Benjouad A; Dejean A; Pineau P; Benjelloun S
    Cancer Epidemiol; 2012 Oct; 36(5):e300-5. PubMed ID: 22709982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
    Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
    Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
    Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
    Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps.
    Jung AY; Poole EM; Bigler J; Whitton J; Potter JD; Ulrich CM
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):330-8. PubMed ID: 18268116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
    Xiong XD; Fang JH; Qiu FE; Zhao J; Cheng J; Yuan Y; Li SP; Zhuang SM
    Mutat Res; 2008 Aug; 643(1-2):70-4. PubMed ID: 18640135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
    Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.